Gilead's HIV portfolio remains dominant but faces Medicare Part D pricing pressure, limiting future growth potential. New ...

This installment of Who Asked? by staff writer Brynn Murawski wonders why it feels like you’ve only accomplished something if ...

One such strategy is test-to-scale — close cousin of the venerable test-and-learn approach that’s long been a startup staple.

The prevailing business leadership advice has always assumed that goal setting is a top-down process. During my time at ...